Plasma 5α–androstane–3α,17βdiol, an endogenous steroid that positively modulates GABAA receptor function, and anxiety: a study in menopausal women
- 31 October 2000
- journal article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 25 (7) , 659-675
- https://doi.org/10.1016/s0306-4530(00)00017-2
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Modulation of GABA-Gated Chloride Ion Influx in the Brain by Dehydroepiandrosterone and Its MetabolitesBiochemical and Biophysical Research Communications, 1998
- Neurosteroids act on the GABAA receptor at sites on the N-terminal side of the middle of TM2NeuroReport, 1998
- Behavioral pharmacology of N-methyl-{d}-aspartate antagonists: Implications for the study and pharmacology of anxiety and schizophrenia.Experimental and Clinical Psychopharmacology, 1997
- Hormones and depression: What are the facts about premenstrual syndrome, menopause, and hormone replacement therapy?American Journal of Obstetrics and Gynecology, 1995
- Affective Symptoms in Women Attending a Menopause ClinicThe British Journal of Psychiatry, 1994
- Dehydroepiandrosterone enhances the hypnotic and hypothermic effects of ethanol and pentobarbitalPharmacology Biochemistry and Behavior, 1992
- Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cellsClinical Immunology and Immunopathology, 1991
- Determination of dehydroepiandrosterone and dehydroepiandrosterone sulphate in blood and tissue. Studies of normal women and women with breast or endometrial cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- Steroid Hormone Metabolites Are Barbiturate-Like Modulators of the GABA ReceptorScience, 1986
- Validity of the Zung Self-rating Depression ScaleThe British Journal of Psychiatry, 1978